MTOR and cervical carcinoma: The effects of mTOR inhibition were further evaluated in an additional panel of 29 human cancer cell lines from diverse tissue origins, including pancreatic, breast, prostate, colon, liver, lung, ovarian, cervical cancers and melanoma.